Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim
--------------------------------------------------------------------
Source: The Jerusalem Post
Published: 2026-06-25 23:49 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Technology & AI, Germany, Drugs, Business & Economy, Technology
--------------------------------------------------------------------
Snippet:
Israeli-founded AI biotech company Immunai announced Thursday a new discovery collaboration with German pharmaceutical giant Boehringer Ingelheim aimed at identifying novel T-cell targets across immuno-oncology and autoimmune diseases.
--------------------------------------------------------------------